CIK 0001621227
- Non-accelerated filer
- Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +44 1235430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-09-01 | Rawcliffe Adrian Chief Executive Officer | Sale | −2,536 | $1.97 | $5K | 3,316 |
| 2022-06-27 | Rawcliffe Adrian Chief Executive Officer | Sale | −2,562 | $1.63 | $4K | 3,290 |
| 2022-01-18 | Rawcliffe Adrian Chief Executive Officer | Sale | −11,096 | $3.19 | $35K | 12,312 |
| 2022-01-12 | Rawcliffe Adrian Chief Executive Officer | Sale | −3,046 | $3.54 | $11K | 3,356 |
| 2022-01-12 | Rawcliffe Adrian Chief Executive Officer | Grant or award · Option to purchase Ordinary Shares | +4,690,224 | 4,690,224 | ||
| 2022-01-12 | Rawcliffe Adrian Chief Executive Officer | Grant or award · Option to purchase Ordinary Shares | +1,047,480 | 1,047,480 | ||
| 2022-01-11 | Rawcliffe Adrian Chief Executive Officer | Sale | −14,362 | $3.56 | $51K | 15,978 |
| 2022-01-04 | Rawcliffe Adrian Chief Executive Officer | Sale | −5,532 | $4.06 | $22K | 6,172 |
| 2021-09-01 | Rawcliffe Adrian Chief Executive Officer | Sale | −2,782 | $5.20 | $14K | 3,070 |
| 2021-06-28 | Rawcliffe Adrian Chief Executive Officer | Sale | −2,794 | $4.37 | $12K | 3,058 |
| 2021-01-19 | Rawcliffe Adrian Chief Executive Officer | Sale | −9,879 | $5.67 | $56K | 13,529 |
| 2021-01-12 | Rawcliffe Adrian Chief Executive Officer | Sale | −2,707 | $6.15 | $17K | 3,695 |
| 2021-01-11 | Rawcliffe Adrian Chief Executive Officer | Grant or award · Option to purchase Ordinary Shares | +3,260,400 | 3,260,400 | ||
| 2021-01-11 | Rawcliffe Adrian Chief Executive Officer | Grant or award · Option to purchase Ordinary Shares | +728,160 | 728,160 | ||
| 2021-01-04 | Rawcliffe Adrian Chief Executive Officer | Sale | −4,967 | $5.33 | $26K | 6,737 |
| 2020-09-01 | Rawcliffe Adrian Chief Executive Officer | Sale | −2,776 | $8.51 | $24K | 3,076 |
| 2020-08-03 | Rawcliffe Adrian Chief Executive Officer | Sale | −2,788 | $9.25 | $26K | 3,064 |
| 2020-01-16 | Rawcliffe Adrian Chief Executive Officer | Grant or award · Option to purchase Ordinary Shares | +2,515,536 | 2,515,536 | ||
| 2020-01-16 | Rawcliffe Adrian Chief Executive Officer | Grant or award · Option to purchase Ordinary Shares | +561,792 | 561,792 | ||
| 2020-01-14 | Rawcliffe Adrian Chief Executive Officer | Sale | −3,236 | $5.13 | $17K | 3,166 |
Page 2 of 3 · 53 trades